Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Financially Strong Stock to Buy Now for an Upside of 40%; Are You Holding It?

India, April 6 -- This article outlines HSBC's bullish view on ITC Hotels, highlighting a 40 percent upside. It discusses steady Q4 FY26 performance, robust domestic demand offsetting geopolitical cha... Read More


Union Bank of India rises as domestic advances grow 10% YoY in Q4 FY26

Mumbai, April 6 -- Domestic deposits grew 2.72% YoY to Rs 13,06,297 crore, while rising 6.88% QoQ as of 31 March 2026. Domestic CASA deposits stood at Rs 4,59,988 crore, increasing 7.90% YoY and 10.82... Read More


Wireless Festival promoter defends Kanye West booking, urges critics to show forgiveness

Kuala Lampur, April 6 --   LONDON, April 7 - One of the promoters of an annual London music festival yesterday defended plans for Kanye West to headline it, amid a backlash over the US rapp... Read More


8 years on, construction on Narsingdi Hospital's new building remains incomplete

Dhaka, April 6 -- The construction of a new building for the 100-bed district hospital in Narsingdi has not been completed in eight years. Meanwhile, patient services are being disrupted due to lack o... Read More


Tata Group Stock Skyrockets 8% After Its Revenue Increases 20% YoY

India, April 6 -- This Tata Group retail player is in focus as its shares surged 8 percent in today's session, outperforming the broader market after reporting a strong Q4 business update. The rally c... Read More


Bank of Baroda gains as global advances grow 16% YoY in Q4 FY26

Mumbai, April 6 -- The bank's global business stood at Rs 30,78,854 crore, registering a growth of 13.93% YoY compared to Rs 27,02,496 crore as of 31 March 2025. Global deposits increased 12.00% YoY t... Read More


Goldiam Int. opens ORIGEM stores at Hyderabad and Bangalore

Mumbai, April 6 -- Goldiam International has opened its 22nd and 23rd retail stores for lab-grown diamond jewellery under the brand name "ORIGEM" at the following locations, which commenced operation... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 6 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More